ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2507

ZCCHC6 Modulates the Global Phosphorylation Landscape in TNF-a-induced Rheumatoid Arthritis Synovial Fibroblasts

Anil Singh, Farheen Sultan Shaikh and Salahuddin Ahmed, Washington State university, Spokane, WA

Meeting: ACR Convergence 2023

Keywords: Cell-signalling molecules, Epigenetics, Fibroblasts, Synovial, rheumatoid arthritis, Tumor necrosis factor (TNF)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: Abstracts: Cytokines & Cell Trafficking

Session Type: Abstract Session

Session Time: 4:00PM-5:30PM

Background/Purpose: ZCCHC6, also known as TUT7 or TENT2, plays a crucial role in RNA processing and metabolism through its uridylyl transferase function. This function involves adding uridine residues to the 3′ ends of RNA molecules, including mRNA and microRNAs and is important for regulating RNA stability, decay, and turnover. However, its role in pro-inflammatory cytokines, such as IL-1β and TNF-α induced inflammatory function, remains elusive.

Methods: To investigate the role of ZCCHC6 in TNF-α-induced inflammation, RNA-seq analysis was performed in human rheumatoid arthritis synovial fibroblasts (RASFs) treated with TNF-α alone or with ZCCHC6 knockdown using siRNA method. Mass Spectrometry based untargeted phospho-proteomics analysis was conducted to determine changes in the global phosphorylation landscape of RASFs treated with ZCCHC6 siRNA in the presence of TNF-α stimulation. Additionally, Gene Ontology studies, ELISA, quantitative RT-PCR, and Western blot analyses were performed to determine the effect on inflammatory responses in TNF-α-activated RASFs with or without ZCCHC6 knockdown. The experiments were carried out using at least three RASF donor lines, with statistical significance set at p< 0.05.

Results: ZCCHC6 knockdown in human RASFs resulted in the differential regulation of 835 genes in the presence of TNF-α. Out of these genes, 384 genes were upregulated, whereas 451 genes were downregulated by at least 2-fold (N=3, p< 0.05). ZCCHC6 exhibited anti-inflammatory effects in TNF-α-stimulated RASFs, as its knockdown by targeted siRNA by enhanced the phosphorylation of signaling proteins important in MAPK-activated pathways, including ASK1, cJun, pERK, p38, pP65, and SAPK/JNK proteins (N=3, p< 0.05). The MS-based phospho-proteomic analysis confirmed that ZCCHC6 knockdown selectively influenced the phosphorylation of 263 unique proteins (N=3, p< 0.05). Gene Ontology studies revealed the upregulation of key pathways, such as mRNA metabolism, apoptosis, DNA damage, and cellular localization. Further analysis demonstrated critical changes in the cellular activity of phosphorylation events that are tightly regulated by Protein Phosphatase 2A (PP2A), a serine/threonine phosphatase. A loss of ZCCHC6 inhibited the TNF-α-induced expression of three regulatory subunits of PP2A, including the structural subunit (A), catalytic subunit (C), and regulatory subunit (B).

Conclusion: This study unveils a novel axis involving ZCCHC6 and TNF-α in the progression of RA. TNF-α utilizes ZCCHC6 to mediate internal phosphorylation signaling events, positively influencing Protein Phosphatase activity, and driving the pathological processes underlying inflammation in RA.


Disclosures: A. Singh: None; F. Shaikh: None; S. Ahmed: None.

To cite this abstract in AMA style:

Singh A, Shaikh F, Ahmed S. ZCCHC6 Modulates the Global Phosphorylation Landscape in TNF-a-induced Rheumatoid Arthritis Synovial Fibroblasts [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/zcchc6-modulates-the-global-phosphorylation-landscape-in-tnf-a-induced-rheumatoid-arthritis-synovial-fibroblasts/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/zcchc6-modulates-the-global-phosphorylation-landscape-in-tnf-a-induced-rheumatoid-arthritis-synovial-fibroblasts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology